VANI
Vivani Medical Inc
$
1.520
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.525
Open
1.440
VWAP
1.48
Vol
336.51K
Mkt Cap
90.05M
Low
1.400
Amount
497.78K
EV/EBITDA(TTM)
--
Total Shares
54.98M
EV
83.26M
EV/OCF(TTM)
--
P/S(TTM)
--
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
--
--
-0.100
-9.09%
--
--
-0.100
-9.09%
--
--
-0.110
-0%
Estimates Revision
The market is revising No Change the revenue expectations for Vivani Medical, Inc. (VANI) for FY2025, with the revenue forecasts being adjusted by % over the past three months. During the same period, the stock price has changed by 10.14%.
EPS Estimates for FY2025
Revise Upward
+6.1%
In Past 3 Month
Stock Price
Go Up
+10.14%
In Past 3 Month
2 Analyst Rating
Wall Street analysts forecast VANI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VANI is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.520
Low
4.00
Averages
4.00
High
4.00
Current: 1.520
Low
4.00
Averages
4.00
High
4.00
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-16
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-16
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-04
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-04
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-26
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-26
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-13
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-13
Reiterates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Vivani Medical Inc (VANI.O) is -3.67, compared to its 5-year average forward P/E of -2.45. For a more detailed relative valuation and DCF analysis to assess Vivani Medical Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.45
Current PE
-3.67
Overvalued PE
-1.33
Undervalued PE
-3.57
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-0.96
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
1.18
Undervalued EV/EBITDA
-3.09
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.01
Current PS
1.47
Overvalued PS
0.16
Undervalued PS
-0.13
Financials
Annual
Quarterly
FY2025Q2
N/A
Total Revenue
FY2025Q2
YoY :
+31.35%
-7.46M
Operating Profit
FY2025Q2
YoY :
+33.38%
-7.14M
Net Income after Tax
FY2025Q2
YoY :
+20.00%
-0.12
EPS - Diluted
FY2025Q2
YoY :
+27.28%
-6.16M
Free Cash Flow
FY2025Q2
N/A
Gross Profit Margin - %
FY2025Q2
N/A
FCF Margin - %
FY2025Q2
N/A
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 232.64% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
3
10.4M
USD
Months
3-6
0
0.0
USD
Months
6-9
16
271.4K
USD
Months
0-12
1
1.1K
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 232.64% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
3
10.4M
USD
Months
3-6
0
0.0
USD
Months
6-9
16
271.4K
USD
Months
0-12
1
1.1K
USD
Months
VANI News & Events
Events Timeline
2025-10-03 (ET)
2025-10-03
08:32:14
Vivani Medical cancels record date for Cortigent spin-off
2025-09-17 (ET)
2025-09-17
08:39:00
Vivani Medical reveals plans to spin off its Cortigent subsidiary
2025-09-04 (ET)
2025-09-04
08:33:48
Vivani Medical shares progress on NPM-139 semaglutide implant development
Sign Up For More Events
Sign Up For More Events
News
8.5
10-29NASDAQ.COMGNTA, BBIO, AMRN Surge in After-Hours Trading: Major Biotech Factors Fueling Stock Increases
8.5
10-27SeekingAlphaVivani Medical sets share price at $1.62 for $16M offering
1.0
10-22NewsfilterVivani Medical to Showcase at ThinkEquity Conference on October 30, 2025
Sign Up For More News
People Also Watch
BNR
Burning Rock Biotech Ltd
11.790
USD
-3.76%
LSF
Laird Superfood Inc
4.150
USD
+2.47%
CLSD
Clearside Biomedical Inc
3.720
USD
-7.46%
LODE
Comstock Inc
2.750
USD
+1.48%
FUSB
First US Bancshares Inc
13.200
USD
+0.23%
NSPR
InspireMD Inc
1.810
USD
-7.65%
OPTX
Syntec Optics Holdings Inc
2.180
USD
-2.24%
XGN
Exagen Inc
9.560
USD
-7.90%
PMVP
PMV Pharmaceuticals Inc
1.310
USD
+4.80%
FAQ
What is Vivani Medical Inc (VANI) stock price today?
The current price of VANI is 1.52 USD — it has increased 3.4 % in the last trading day.
What is Vivani Medical Inc (VANI)'s business?
What is the price predicton of VANI Stock?
What is Vivani Medical Inc (VANI)'s revenue for the last quarter?
What is Vivani Medical Inc (VANI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Vivani Medical Inc (VANI)'s fundamentals?
How many employees does Vivani Medical Inc (VANI). have?